These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1727 related articles for article (PubMed ID: 30480778)
21. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751 [TBL] [Abstract][Full Text] [Related]
22. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer. Wagner AD; Thomssen C; Haerting J; Unverzagt S Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517 [TBL] [Abstract][Full Text] [Related]
23. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma. Lawrie TA; Gillespie D; Dowswell T; Evans J; Erridge S; Vale L; Kernohan A; Grant R Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013047. PubMed ID: 31425631 [TBL] [Abstract][Full Text] [Related]
28. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy. Chan KK; Glenny AM; Weldon JC; Furness S; Worthington HV; Wakeford H Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010341. PubMed ID: 26625332 [TBL] [Abstract][Full Text] [Related]
29. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]